Live Demo Agent Trial
Live Demo Agent Trial Log In Sign Up
News Wire / health

FDA Authorizes Fruit-Flavored E-Cigarettes For Adults

WBUR Boston Washington DC 13d7d Impact 8

The FDA has authorized initial testing of a drug related to ibogaine for individuals with alcohol use disorder. Potential risks include abuse potential and traumatic side effects, though the substance is considered reasonably safe under controlled settings. The program is expected to resume normal operations tomorrow. Gale Saltz of Weill Cornell Medical College discussed the announcement, noting that previous MDMA applications faced rejection in 2024 due to geopolitical concerns. The agency is currently considering methamphetamine as an alternative due to fewer side effects. The FDA has authorized clinical testing of ibogaine, a hallucinogenic substance derived from an African shrub, to treat alcohol use disorder. Reports indicate potential success in reducing cravings after a single session. Ongoing clinical trials are required to confirm these findings.

The FDA has authorized initial testing of a drug related to ibogaine for individuals with alcohol use disorder. Potential risks include abuse potential and traumatic side effects, though the substance is considered reasonably safe under controlled settings. The program is expected to resume normal operations tomorrow. Gale Saltz of Weill Cornell Medical College discussed the announcement, noting that previous MDMA applications faced rejection in 2024 due to geopolitical concerns. The agency is currently considering methamphetamine as an alternative due to fewer side effects. The FDA has authorized clinical testing of ibogaine, a hallucinogenic substance derived from an African shrub, to treat alcohol use disorder. Reports indicate potential success in reducing cravings after a single session. Ongoing clinical trials are required to confirm these findings. The Food and Drug Administration has authorized fruit-flavored electronic cigarettes intended for adult smokers. This decision follows months of appeals from the vaping industry to the White House. The new products include fruit, mint, and menthol flavors. The announcement comes despite presidential candidate Donald Trump's previous promises to support the vaping industry.

Topics

FDA psychedelics alcohol use disorder

Developing

  1. 863d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
  2. 863d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
  3. 863d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
  4. 863d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.

Sources · 7 independent

WBUR Boston

“the FDA has authorized initial testing of a drug related to Ibogaine for people with alcohol use disorder. It's another powerful psychedelic.”

WBUR Boston

“the FDA has authorized initial testing of a drug related to Ibogaine for people with alcohol use disorder.”

WBUR Boston

“are very ill patients and close to a 50% response rate is It's going to be open tomorrow and everything's back to normal again. It's a big deal.”

WBUR Boston

“The FDA announcing expedited reviews of some psychedelic drug products. The third and final one I want to kind of ask you about, Ibogaine, is being tested to treat alcohol abuse.”

WBUR Boston

“treat alcohol abuse. Tell me about that. yet and other abuse disorders”

WBUR Boston

“And so that's why- And I know this has just gotten a lot of recent attention, but from an African shrub, this is a hallucinogenic as well.”

KYW Newsradio 1060

“The announcement from the Food and Drug Administration is a major shift that comes after months of appeals to the White House from the vaping industry.”

Unlock the full story

Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.

Log in to upgrade